Real-world safety and effectiveness of enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma: A multicenter Japanese cohort study.
Saved in:
| Title: | Real-world safety and effectiveness of enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma: A multicenter Japanese cohort study. |
|---|---|
| Authors: | Yanagisawa T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan. Electronic address: t.yanagisawa.jikei@gmail.com., Iwatani K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Urabe F; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Tsujino T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan., Uchimoto T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan., Inoki L; Department of Urology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan., Hashimoto M; Department of Urology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan., Yamamoto Y; Department of Urology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan., Nukaya T; Department of Urology, Fujita-Health University School of Medicine, Toyoake, Aichi, Japan., Nishio K; Department of Urology, Kawasaki Medical School, Kurashiki, Okayama, Japan., Tamura K; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan., Fukuokaya W; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Takahara K; Department of Urology, Fujita-Health University School of Medicine, Toyoake, Aichi, Japan., Fujita K; Department of Urology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan., Azuma H; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan., Inamoto T; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan., Komura K; Department of Urology, Kawasaki Medical School, Kurashiki, Okayama, Japan., Kimura T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan. |
| Corporate Authors: | ULTRA-J consortium |
| Source: | Urologic oncology [Urol Oncol] 2026 Jul 17. Date of Electronic Publication: 2026 Jul 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 9805460 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2496 (Electronic) Linking ISSN: 10781439 NLM ISO Abbreviation: Urol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42469056 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Real-world safety and effectiveness of enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma: A multicenter Japanese cohort study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Yanagisawa+T%22">Yanagisawa T</searchLink>; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan. Electronic address: t.yanagisawa.jikei@gmail.com.<br /><searchLink fieldCode="AU" term="%22Iwatani+K%22">Iwatani K</searchLink>; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Urabe+F%22">Urabe F</searchLink>; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tsujino+T%22">Tsujino T</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Uchimoto+T%22">Uchimoto T</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Inoki+L%22">Inoki L</searchLink>; Department of Urology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Hashimoto+M%22">Hashimoto M</searchLink>; Department of Urology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Yamamoto+Y%22">Yamamoto Y</searchLink>; Department of Urology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Nukaya+T%22">Nukaya T</searchLink>; Department of Urology, Fujita-Health University School of Medicine, Toyoake, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Nishio+K%22">Nishio K</searchLink>; Department of Urology, Kawasaki Medical School, Kurashiki, Okayama, Japan.<br /><searchLink fieldCode="AU" term="%22Tamura+K%22">Tamura K</searchLink>; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Fukuokaya+W%22">Fukuokaya W</searchLink>; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Takahara+K%22">Takahara K</searchLink>; Department of Urology, Fujita-Health University School of Medicine, Toyoake, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Fujita+K%22">Fujita K</searchLink>; Department of Urology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Azuma+H%22">Azuma H</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Inamoto+T%22">Inamoto T</searchLink>; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Komura+K%22">Komura K</searchLink>; Department of Urology, Kawasaki Medical School, Kurashiki, Okayama, Japan.<br /><searchLink fieldCode="AU" term="%22Kimura+T%22">Kimura T</searchLink>; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22ULTRA-J+consortium%22">ULTRA-J consortium</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229805460%22">Urologic oncology</searchLink> [Urol Oncol] 2026 Jul 17. <i>Date of Electronic Publication: </i>2026 Jul 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9805460 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2496 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210781439%22">10781439 </searchLink><i>NLM ISO Abbreviation: </i>Urol Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42469056 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.urolonc.2026.06.019 Languages: – Code: eng Text: English Titles: – TitleFull: Real-world safety and effectiveness of enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma: A multicenter Japanese cohort study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yanagisawa T – PersonEntity: Name: NameFull: Iwatani K – PersonEntity: Name: NameFull: Urabe F – PersonEntity: Name: NameFull: Tsujino T – PersonEntity: Name: NameFull: Uchimoto T – PersonEntity: Name: NameFull: Inoki L – PersonEntity: Name: NameFull: Hashimoto M – PersonEntity: Name: NameFull: Yamamoto Y – PersonEntity: Name: NameFull: Nukaya T – PersonEntity: Name: NameFull: Nishio K – PersonEntity: Name: NameFull: Tamura K – PersonEntity: Name: NameFull: Fukuokaya W – PersonEntity: Name: NameFull: Takahara K – PersonEntity: Name: NameFull: Fujita K – PersonEntity: Name: NameFull: Azuma H – PersonEntity: Name: NameFull: Inamoto T – PersonEntity: Name: NameFull: Komura K – PersonEntity: Name: NameFull: Kimura T IsPartOfRelationships: – BibEntity: Dates: – D: 17 M: 07 Text: 2026 Jul 17 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1873-2496 Titles: – TitleFull: Urologic oncology Type: main |
| ResultId | 1 |